Leslie Meltzer

Chief Research and Development at Apellis Pharmaceuticals · 2 reported transactions in 1 company · latest report Jan 28, 2026

Their trades


Apellis PharmaceuticalsAPLS	Share award — · 45,220 shares	Jan 28, 2026
Apellis PharmaceuticalsAPLS	Share award — · 61,804 shares	Aug 26, 2025

Jan 28, 2026 · APLS

45,220

Aug 26, 2025 · APLS

61,804

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Research and Development at Apellis Pharmaceuticals · 2 reported transactions in 1 company · latest report Jan 28, 2026


Apellis PharmaceuticalsAPLS	Share award — · 45,220 shares	Jan 28, 2026
Apellis PharmaceuticalsAPLS	Share award — · 61,804 shares	Aug 26, 2025

Jan 28, 2026 · APLS

45,220

Aug 26, 2025 · APLS

61,804

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.